Risk assessment and factor VIII concentrates.
Hughes-Jones
N C
NC
Molecular Immunopathology Unit, MRC Centre, Cambridge, UK.
D005169:Factor VIII / Q000009:adverse effects*; D015658:HIV Infections / Q000635:transmission*; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans; D018570:Risk Assessment
D005169:Factor VIII